EI- Nile for Pharmaceuticals and Chemical Industries Balance Sheet Health
Financial Health criteria checks 4/6
EI- Nile for Pharmaceuticals and Chemical Industries has a total shareholder equity of EGP457.1M and total debt of EGP505.4M, which brings its debt-to-equity ratio to 110.6%. Its total assets and total liabilities are EGP1.6B and EGP1.1B respectively. EI- Nile for Pharmaceuticals and Chemical Industries's EBIT is EGP74.4M making its interest coverage ratio 3.2. It has cash and short-term investments of EGP17.2M.
Key information
110.6%
Debt to equity ratio
ج.م505.39m
Debt
| Interest coverage ratio | 3.2x |
| Cash | ج.م17.16m |
| Equity | ج.م457.12m |
| Total liabilities | ج.م1.11b |
| Total assets | ج.م1.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NIPH's short term assets (EGP834.7M) exceed its short term liabilities (EGP758.3M).
Long Term Liabilities: NIPH's short term assets (EGP834.7M) exceed its long term liabilities (EGP353.3M).
Debt to Equity History and Analysis
Debt Level: NIPH's net debt to equity ratio (106.8%) is considered high.
Reducing Debt: NIPH's debt to equity ratio has increased from 19.5% to 110.6% over the past 5 years.
Debt Coverage: NIPH's debt is well covered by operating cash flow (49%).
Interest Coverage: NIPH's interest payments on its debt are well covered by EBIT (3.2x coverage).